Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-197858
Filing Date
2026-04-30
Accepted
2026-04-30 17:19:54
Documents
64
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fblg-20260331.htm   iXBRL 10-Q 1623580
2 EX-31.1 fblg-ex31_1.htm EX-31.1 16420
3 EX-31.2 fblg-ex31_2.htm EX-31.2 16366
4 EX-32.1 fblg-ex32_1.htm EX-32.1 7817
  Complete submission text file 0001193125-26-197858.txt   6648380

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fblg-20260331.xsd EX-101.SCH 916283
68 EXTRACTED XBRL INSTANCE DOCUMENT fblg-20260331_htm.xml XML 1099422
Mailing Address 9350 KIRBY DRIVE SUITE 300 HOUSTON TX 77054
Business Address 9350 KIRBY DRIVE SUITE 300 HOUSTON TX 77054 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41934 | Film No.: 26927283
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)